- Home
- RLMD vs EIKN Comparison
RLMD vs EIKN Comparison
Compare RLMD & EIKN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RLMD | EIKN |
|---|---|---|
| Founded | 2004 | 2019 |
| Country | United States | United States |
| Employees | 17 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 661.9M | 731.6M |
| IPO Year | 2012 | N/A |
Fundamental Metrics
Financial Performance| Metric | RLMD | EIKN |
|---|---|---|
| Price | $5.93 | $8.92 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 6 |
| Target Price | $12.40 | ★ $25.60 |
| AVG Volume (30 Days) | ★ 925.0K | 352.9K |
| Earning Date | 05-08-2026 | 03-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 45.28 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $13,070.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 154.83 | N/A |
| 52 Week Low | $0.52 | $7.90 |
| 52 Week High | $8.00 | $16.50 |
Technical Indicators
Market Signals| Indicator | RLMD | EIKN |
|---|---|---|
| Relative Strength Index (RSI) | 32.00 | 39.81 |
| Support Level | $5.68 | $8.74 |
| Resistance Level | $7.46 | $12.16 |
| Average True Range (ATR) | 0.41 | 1.05 |
| MACD | -0.14 | -0.21 |
| Stochastic Oscillator | 5.11 | 2.13 |
Price Performance
Historical ComparisonAbout RLMD Relmada Therapeutics Inc.
Relmada Therapeutics Inc is a clinical-stage, publicly traded biotechnology company focused on the development of NDV-01 and sepranolone. NDV-01 is a novel, controlled-release intravesical formulation of gemcitabine and docetaxel. NDV-01 is currently in a Phase 2 clinical trial in Isreal to assess its safety and efficacy in patients with aggressive forms of non-muscle invasive bladder cancer (NMIBC). Sepranolone is a novel neurosteroid epimer of allopregnanolone. sepranolone is being developed for the potential treatment of Prader-Willi Syndrome, Tourette Syndrome, excessive tremor and other diseases related to excessive GABAergic activity.